HUBs will enhance community engagement and provide a local resource for cancer-related education and navigation support for cancer services.
You might find a hangover cure, protection against Alzheimer’s and much more in nature’s bounty.
USC physician-scientists look for promising treatments for colorectal cancer on a postage stamp-size chip.
A nationally recognized leader in cancer prevention and minority health research, she has dedicated her career to reducing the disparities in cancer outcomes that affect patients from underrepresented communities.
Peter Kuhn of the USC Michelson Center for Convergent Bioscience will serve as deputy director of a new virtual cancer center, funded by a grant from the Department of Defense.
A decade after surviving lymphoma as a child, a young woman gets critical guidance from a USC doctor about her fertility.
Dedicated space for the Convergent Science Institute in Cancer initiative aims to get biologists, physicists and chemists collaborating on cutting-edge ideas that benefit patients.
Tracking the physical activity levels of people receiving chemotherapy can improve their care and even predict emergency room visits, according to USC research.
Sophie Mansfield started out as a high school student in a special program at the Lawrence J. Ellison Institute for Transformative Medicine of USC. Learn how the USC graduate now works equity in cancer care.
The research — co-led by the USC Norris Comprehensive Cancer Center — identified 86 new genetic variations that increase the risk of prostate cancer.
Big data studies in diverse populations will offer new insights into cancer risk and help USC investigators target outreach, screening and prevention efforts.
Tobacco smoking is the leading cause of bladder cancer, but this is the first study to suggest that smoking puts bladder cancer patients at risk after their diagnosis.
A USC study suggests that high-intensity focused ultrasound ablation is an effective alternative to surgery or radiation, with shortened recovery time.
The emeritus professor of pediatrics was influential in the establishment of the cancer center.
USC research has uncovered that commonly used coloring agents like tattoo inks and food dyes can illuminate cancer cells, differentiating them from normal adjacent cells.
The guidelines evaluate existing research and treatment options for clinicians and patients to maximize lymphedema volume-reducing treatment.
Inspired by his father’s fight against non-Hodgkin’s lymphoma, Remo Rohs leads USC’s efforts in studying the molecular nature of cancer.
USC researchers are using AI to fuel more confident diagnosis of renal tumors, as well as more customized treatment for cancer patients and patients infected with COVID-19.
The tool, developed by USC researchers, could help identify patients with the most to gain from a clinical trial as well as guide therapeutic targets.
The renowned oncologist and cancer researcher will join USC in this newly created position in September.
A USC-led team of international scientists found that a one-two punch of a fasting-mimicking diet with hormone therapy may enhance the effects of breast cancer treatment.
A Keck Medicine of USC study found that socioeconomic status plays an important role in access to chemotherapy.
The gift creates and supports the Rosalie and Harold Rae Brown Center for Cancer Drug Discovery, which will focus on accelerating the development of groundbreaking cancer treatments.
Chemical engineers at USC Viterbi have unlocked a fatal vulnerability in many cancer cells: sugar inflexibility.